THOMAS BOSMA: Open Payments
NPI 1255434544 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,485 in 50 payments from 20 companies in 2025. Trend: 2023 $986 · 2024 $1,361 · 2025 $1,485
Food & beverage: $1,400Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $303 |
| Janssen Biotech, Inc. | 3 | $148 |
| Astellas Pharma US Inc | 2 | $148 |
| Sumitomo Pharma America, Inc. | 9 | $145 |
| PFIZER INC. | 4 | $112 |
| Alnylam Pharmaceuticals Inc. | 3 | $93 |
| Procept Biorobotics Corporation | 1 | $87 |
| Antares Pharma, Inc. | 3 | $74 |
| Endo USA, Inc. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
Products named: BOTOX, ERLEADA, XTANDI, Padcev, OXLUMO, AQUABEAM ROBOTIC SYSTEM, ORGOVYX, XYOSTED.
Industry payments across CA — which companies pay providers there.
